Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of HP-3000 (ropinirole patch) in idiopathic restless legs syndrome
jRCT2080222232Phase 2
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in restless legs syndrome (RLS) comparing HP-3000 ropinirole patch with HP-3000 placebo patch (2 arms).
02
Drugs
ropinirole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on jRCT2080222232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222232.